Internal Medicine, Hematology & Oncology · Scottsdale, AZ
NPI
1679661490
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
13400 E Shea Blvd
Scottsdale, AZ, 85259
Phone (480) 301-8845
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.3M
93,107 services
Medicare patients, 2024
710
Average age 74
Drug cost, 2024
$556K
395 prescriptions
Company payments, 2025
$0
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Nina J Karlin was code J9271 (injection, pembrolizumab, 1 mg), 9,800 times for 42 patients. In total Nina J Karlin billed 93,107 services in 148 codes, and Medicare paid $2.3M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-09-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J9271 Injection, pembrolizumab, 1 mg | Office | 9,800 | 42 | $44.87 | $440K |
| J9144 Injection, daratumumab, 10 mg and hyaluronidase-fihj | Office | 9,360 | 43 | $39.05 | $365K |
| J1453 Injection, fosaprepitant, 1 mg | Office | 6,600 | 40 | $0.11 | $709 |
| J9177 Injection, enfortumab vedotin-ejfv, 0.25 mg | Office | 5,180 | 14 | $28.79 | $149K |
| J9299 Injection, nivolumab, 1 mg | Office | 4,500 | 11 | $24.57 | $111K |
| J9263 Injection, oxaliplatin, 0.5 mg | Office | 3,300 | 13 | $0.05 | $172 |
| J9267 Injection, paclitaxel, 1 mg | Office | 2,634 | 12 | $0.08 | $210 |
| J9047 Injection, carfilzomib, 1 mg | Office | 1,770 | 11 | $37.67 | $67K |
| J0897 Injection, denosumab, 1 mg | Office | 1,740 | 12 | $20.23 | $35K |
| Q5115 Injection, rituximab-abbs, biosimilar, (truxima), 10 mg | Office | 1,270 | 18 | $25.84 | $33K |
| J1569 Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | Office | 1,220 | 20 | $36.45 | $44K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 774 | 65 | $0.09 | $69.49 |
| J9041 Injection, bortezomib, 0.1 mg | Office | 725 | 15 | $1.29 | $938 |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 690 | 62 | $0.66 | $459 |
| J2405 Injection, ondansetron hydrochloride, per 1 mg | Office | 500 | 56 | $0.07 | $36.93 |
By year: 2022 $1.5M for 74,625 services; 2023 $1.7M for 88,185 services; 2024 $2.3M for 93,107 services.
Medicare prescription drug claims, 2024
In 2024, the drug Nina J Karlin prescribed most often to Medicare patients was Dexamethasone, with 89 prescriptions and refills. In total Nina J Karlin wrote 395 Medicare prescriptions that cost $556K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Dexamethasone Generic | 89 | 89 | 30 | $466 |
| Prochlorperazine Maleate Generic | 57 | 57 | 36 | $577 |
| Ondansetron Hcl Generic | 54 | 54 | 38 | $446 |
| Olanzapine Generic | 49 | 59 | 30 | $635 |
| Eliquis Apixaban | 21 | 27 | Under 11 | $14K |
| Lenvima Lenvatinib Mesylate | 18 | 18 | Under 11 | $425K |
| Letrozole Generic | 14 | 34 | Under 11 | $166 |
| Lysodren Mitotane | 13 | 13 | Under 11 | $22K |
Brand drugs: 68 claims; generic drugs: 327 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Nina J Karlin $0 (- in general payments such as food, travel and fees) from 1 company.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.